Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Review

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

         
Total article views   Abstract views HTML views PDF downloads Totals
13,848 Dovepress* 13,848 0+ 3,309 13,848
Totals 13,848 0 3,309 13,848
*Since 12 April 2010
+Since July 2016

View citations on Google Scholar